Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

icosapent

icosapent
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Vascepa CAPSULE, ORAL 1 g      
Comments:

Vascepa is approved for sample use in HH Endocrinology and Diabetes Clinics.

Inpatients may use their home supply.

 

Reviewed: January 22, 2013 (Vascepa)

Updated: February 2021 (Automatic Interchange Discontinued)

Last updated: Jan. 17, 2023
  • Therapeutic Interchange






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved